Comparative Study of EnliTuo® Before and After Technology Change in Healthy Male Volunteers

Phase 1 Active not recruiting 86 enrolled Taizhou Mabtech Pharmaceutical Co.,Ltd

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a randomized, double-Blind, parallel-controlled, single-dose pharmacokinetic, safety, and immunogenicity comparative study of EnliTuo® before and after technology change in healthy male volunteers.

Timeline

Start: 2025-11-11
Primary completion: 2026-04-16
Completion: 2026-05-13

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Enlituo	Unknown	250 mg/m2	Intravenous

Indications

No indication recorded.